Search Results 801-810 of 11322 for Antifungal Resistance
... resistance to a particular combination. Participants who do not have accessible or suitable lesions are not eligible. Baseline biopsies may be collected ...
— A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an ...
Understanding and preventing antimicrobial resistance featured image. Infectious Diseases. Understanding and preventing antimicrobial resistance. (VIDEO) ...
Zika virus also may have harmful heart effects, research shows in first report in adults · Mayo Clinic researchers clarify chemo resistance, and perhaps a new ...
This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical ...
Marla Broadfoot, Ph.D. February 23, 2026. Mayo Clinic study identifies mechanism behind immunotherapy resistance in lung cancer ...
Tabaja H, Hindy JR, Kanj SS. Epidemiology of Methicillin-Resistant Staphylococcus Aureus in Arab Countries of the Middle East and North African (MENA) Region.
... resistant). Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an ...
... antifungals within 2 weeks before baseline;; Active acute bacterial, fungal, or viral skin infection (e.g., herpes simplex, herpes zoster, chickenpox ...
... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.